ASHLEY BOGUE: Open Payments
NPI 1538543368 · PLAINVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 80 payments from 18 companies in 2025. Trend: 2023 $46 · 2024 $1,001 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $267 |
| ABBVIE INC. | 12 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $203 |
| GlaxoSmithKline, LLC. | 10 | $200 |
| PFIZER INC. | 9 | $173 |
| Novo Nordisk Inc | 7 | $137 |
| Lilly USA, LLC | 5 | $122 |
| Exact Sciences Corporation | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: CAPLYTA, VRAYLAR, MOUNJARO, FARXIGA, TRELEGY ELLIPTA, ELIQUIS, SHINGRIX, NURTEC ODT.
Industry payments across CT — which companies pay providers there.
